Breaking India’s Education Minister Resigns Amidst ‘Cockroach Movement’ Pressure Indian Youth Lead Protests, Leading to Education Minister’s Resignation Egypt’s Heat Preparedness Questioned Amidst Rising Temperatures Aging Pop Icons Cher, Parton, Streisand, and Warwick Offer Blueprint for ‘Life Well-Lived’ New Tariffs Imposed by Former President Trump Spark Economic Debate

Saturday July 25, 2026

Reporter

Dyne Therapeutics, Inc.

5Articles Published

5Communities Covered

Published Articles

Press Release

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 24

Press Release

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Jul 23

Press Release

Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock

Jul 21

Press Release

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

Jul 21

Press Release

Dyne Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)

Jul 20